EBV LMP2A anticorps
Aperçu rapide pour EBV LMP2A anticorps (ABIN2473474)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Attributs du produit
- Purified IgG
-
Purification
- Purified
-
Immunogène
- Bacterial TrpE-LMP2A fusion protein
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.0 mg/mL
-
-
-
: "Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation." dans: Journal of neuropathology and experimental neurology, Vol. 69, Issue 7, pp. 677-93, (2010) (PubMed).
: "Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22." dans: Neoplasia (New York, N.Y.), Vol. 11, Issue 11, pp. 1174-84, (2009) (PubMed).
-
-
- EBV LMP2A (Epstein-Barr Virus Latent Membrane Protein 2A (EBV LMP2A))
-
Autre désignation
- EPSTEIN-BARR VIRUS LMP2A
-
Classe de substances
- Viral Protein
-
Sujet
- Synonyms: EBV
Antigène
-